The ET AI Awards 2025 MedTech & Healthcare Innovation category honours large healthcare and life sciences organisations that ...
Smart multi-target drugs are redefining how we treat complex diseases by combining AI-driven discovery with mechanistic ...
VANCOUVER, BC / ACCESS Newswire / November 25, 2025 /Variational AI, a leading innovator in generative artificial ...
Digital preservation and transmission of intangible cultural heritage (ICH) are important in preserving cultural identity in the face of modernization. Virtual Reality (VR) technology offers an ...
Artificial intelligence (AI) is revolutionising how scientists study cancer and Type 1 diabetes and discover ways to fight them.
ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.
Nil Adell-Mill is pioneering a new era of chemistry by teaching machines to innovate through biology-inspired models, ...
From target identification and molecular design to patient stratification and clinical trial optimization, artificial intelligence (AI) is showing remarkable promise in accelerating drug discovery and ...
From idea, to lab, to clinic, to approval—it's a long and expensive process to bring a drug to market. It also rarely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback